The purpose of this contract is to produce an inexpensive and easy-to-use sputum processing system that can operate in a low resource clinical setting for on-site molecular testing or transport to a…
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93019C00002
- Awardee
-
Akonni Biosystems Inc. UEI PGLAYC4UKDL7
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,999,954
Award facts
- Opportunity
-
- SBIRPHS20161 Solicitation number
- A Low Cost Integrated Method for Isolation of M. Tuberculosis DNA from Raw Sputum Award Notice · Posted Jul 2, 2015
- Contract value 100% obligated
- $2,999,954.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Frederick, MD 21701, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,999,954 |
About this award
This is a $2,999,954.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Akonni Biosystems Inc., a small business. The contract's purpose is to produce an inexpensive and easy-to-use sputum processing system for on-site molecular testing or transport to a centralized facility in a low-resource clinical setting. The contractor shall deliver a production-equivalent instrument and consumables compliant with CGMP and ISO 13485 design control requirements. The device must meet user needs and product requirements. This contract was awarded under the SBIR Phase II program and has a completion date of March 31, 2022.
Description
The purpose of this contract is to produce an inexpensive and easy-to-use sputum processing system that can operate in a low resource clinical setting for on-site molecular testing or transport to a centralized facility. Upon completion of the contract, the contractor shall have produced a production-equivalent instrument and consumables so that they can be manufactured under cgmp and compliant with the design control requirements of ISO 13485. The device shall have been tested to meet its user needs and product requirements.
Quick answers
Who was awarded contract 75N93019C00002?
75N93019C00002 was awarded to Akonni Biosystems Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 27, 2018.
How much is contract 75N93019C00002 worth?
The government has obligated $2,999,954 on 75N93019C00002.
Was contract 75N93019C00002 competed?
The extent of competition for 75N93019C00002 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award